The Hong Kong government announced that since the two vaccines of Fubitai and Sinovac vaccines have been registered in Hong Kong as Hong Kong pharmaceutical products, the private market will be able to provide vaccination services according to the law (Fubitai, Bivalent Vaccines of Fubitai and Sinovac ).
But at the same time, the vaccine protection fund established by the Hong Kong government will not be applicable to unexpected serious abnormal events caused by the administration of registered new crown vaccines.
The Hong Kong government also announced that due to the tight supply, the Fubitai bivalent vaccine and the formula vaccine for children and young children will be given priority to Hong Kong residents for free vaccination, while non-Hong Kong residents will continue to be provided free of charge. vaccine.
Non-Hong Kong residents can also receive COVID-19 vaccination services outside the government vaccination program at private doctors, clinics and hospitals in Hong Kong at their own expense.
Eligible persons over the age of 12 can receive the bivalent vaccine of Fubita as the fourth dose of vaccine.
(Photo by Jiang Liying)
The fifth shot｜Dr. Lin Yonghe: Bivalent vaccine can reduce the chance of infection and infection Let Fubitai bivalent vaccine be used in young children Pfizer BioNTech applied for emergency use authorization from FDA
